Therapy with interferon-alpha and ribavirin for chronic hepatitis C virus infection upregulates membrane HLA-ABC, CD86, and CD28 on peripheral blood mononuclear cells

Journal of Medical Virology
Pin-Nan ChengKung-Chia Young

Abstract

Multiple interferon-stimulated genes (ISGs) involving T-cell activation are upregulated during initial interferon-alpha-based therapy for chronic hepatitis C virus (HCV) infection. However, the long-term impact on therapeutic outcome in patients remains unknown. In this study, the effects of anti-HCV therapy on the surface expression of HLA-ABC, CD86, and CD28 were longitudinally assessed. These proteins are integral membrane receptors of antigen presentation and triggering of costimulatory signals for activating CD8+ T cells. Peripheral blood mononuclear cells were collected at baseline and post-treatment for 1 day, and 2, 4, 12, and 24 weeks, respectively. This treatment led to a time-related elevation of membrane levels of HLA-ABC and CD86 on B-cells and monocytes in patients with a sustained response (n = 23), but not in those without (n = 8). Meanwhile, upregulation of CD28 on CD4+ and CD8+ T cells was comparable in both groups of sustained responders and non-responders. Steady increases in the B cells' surface and intracellular HLA-ABC were observed, thus, the surface-to-intracellular ratios did not alter over the period of treatment. Furthermore, multivariate analysis shows that increased HLA-ABC on monocytes by week 12 ...Continue Reading

References

Aug 1, 1997·Journal of Hepatology·T HöhlerC Rittner
Jan 13, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N KuzushitaM Hori
Jul 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D R NelsonJ Y Lau
Nov 27, 1998·European Journal of Gastroenterology & Hepatology·I KikuchiK Tamura
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·X S HeH B Greenberg
Feb 26, 2000·Human Immunology·S VejbaesyaT Dharakul
Dec 22, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K M ChangF V Chisari
Apr 23, 2002·Journal of Virology·Chloe L ThioDavid L Thomas
Aug 29, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eleanor BarnesPaul Klenerman
Feb 26, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xuhuai JiXiao-Song He
Apr 30, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Haizhen ZhuChen Liu
Jul 6, 2004·Immunological Reviews·Maurizio ZanettiMara Gerloni
Jan 18, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Li-Yu WangShih-Yen Lo
Jun 18, 2005·Genome Biology·Mary CollinsBeatriz M Carreno
Aug 19, 2005·Nature·Michael Gale, Eileen M Foy
Aug 19, 2005·Nature·David G Bowen, Christopher M Walker
Aug 19, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Karla J HelbigMichael R Beard
Jan 28, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Keyur PatelJohn G McHutchison
Feb 28, 2006·Journal of Gastroenterology·Norio Hayashi, Tetsuo Takehara
Apr 22, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Robert E LanfordCatherine B Bigger

❮ Previous
Next ❯

Citations

Apr 18, 2009·American Journal of Respiratory Cell and Molecular Biology·Lisa C ZabaStephen D Prystowsky
Mar 16, 2012·Scandinavian Journal of Gastroenterology·Sang Jin LeeNeung Hwa Park
Jul 20, 2010·Immunotherapy·Nagendra R HegdeSrinivas V Kaveri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.